Related Experiment Video
Updated: Jan 4, 2026

10:25
Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
Published on: September 25, 2019
49.2K
Data on MRI brain lesion segmentation using K-means and Gaussian Mixture Model-Expectation Maximization
Ju Qiao1, Xuezhu Cai2, Qian Xiao3
1Department of Mechanical and Industrial, Northeastern University, Boston, MA, USA.
Data in Brief
|November 6, 2019
Summary
This study compared K-means and Gaussian Mixture Model-Expectation Maximization (GMM-EM) for brain MRI lesion segmentation. Both methods showed similar performance, with lesion size not impacting accuracy or sensitivity.
Area of Science:
- Medical imaging analysis
- Artificial intelligence in healthcare
Background:
- Accurate segmentation of brain lesions in MRI is crucial for diagnosis and treatment monitoring.
- Automated methods are needed to improve efficiency and consistency in lesion segmentation.
Purpose of the Study:
- To compare the performance of K-means and Gaussian Mixture Model-Expectation Maximization (GMM-EM) algorithms for automatic brain MRI lesion segmentation.
- To evaluate the impact of lesion size on the accuracy and sensitivity of these segmentation methods.
Main Methods:
- Brain MRI data were analyzed using K-means clustering and GMM-EM algorithms for lesion segmentation.
- Performance metrics including accuracy, sensitivity, specificity, false positive rate, and misclassification rate were calculated for both algorithms.
Main Results:
- Both K-means and GMM-EM algorithms demonstrated comparable performance in segmenting brain MRI lesions.
- No significant differences in accuracy, sensitivity, or other performance metrics were found between the two methods.
- Lesion size did not significantly affect the accuracy or sensitivity of either K-means or GMM-EM segmentation.
Conclusions:
- K-means and GMM-EM are both effective and comparable automated methods for brain MRI lesion segmentation.
- These algorithms offer reliable performance regardless of lesion size, aiding in consistent clinical assessment.

